Pfizer has revealed what it will charge for a five-day course of its oral antiviral Paxlovid for COVID-19 when it starts to see it on the commercial market later this year. The drugmaker has set a ...

US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant.

Paxlovid — Pfizer’s combination of nirmatrelvir and ritonavir — has been found to reduce symptoms, hospitalizations and deaths in unvaccinated, at-risk patients. However, a Pfizer trial ...

Appearing in late December 2021, Paxlovid offered a double promise. It was going to save lives and reduce the burden of SARS-CoV-2 infections on hospitals. Developed by the Pfizer laboratory ...

What do you do? Specifically, what's the role of antivirals? You might have heard about a drug called Paxlovid. Well, Paxlovid is a pill that you take by mouth, as opposed to some other therapies ...

REUTERS/Jennifer Lorenzini Brazil's highest health authority approved on Wednesday the emergency use of Paxlovid, the drug developed by US pharmaceutical company Pfizer to treat COVID-19.